Celcuity Inc. (CELC): Shareholders' Equity
$100.56M
As of 2025-12-31
-$12.78M
As of 2026-06-30
-9.1%
3-year compound annual growth
+53.8%
5-year compound annual growth
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $100.56M | -13.0% | 2026-03-26, Balance as of period end |
| 2024-12-31 | $115.62M | -17.3% | 2026-03-26, Balance as of period end |
| 2023-12-31 | $139.77M | +4.5% | 2025-03-31, Balance as of period end |
| 2022-12-31 | $133.77M | +94.7% | 2024-03-27, Balance as of period end |
| 2021-12-31 | $68.71M | +487.2% | 2023-03-23, Balance as of period end |
| 2020-12-31 | $11.70M | -39.4% | 2022-03-23, Balance as of period end |
| 2019-12-31 | $19.30M | -23.9% | 2021-02-16, Balance as of period end |
| 2018-12-31 | $25.35M | -19.2% | 2020-03-13, Balance as of period end |
| 2017-12-31 | $31.39M | +459.4% | 2019-03-01, Balance as of period end |
| 2016-12-31 | $5.61M | n/a | 2018-03-15, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| Celcuity Inc. (CELC) | 2025-12-31 | $100.56M | -13.0% |
| CareDx, Inc. (CDNA) | 2025-12-31 | $303.10M | -19.9% |
| Castle Biosciences Inc (CSTL) | 2025-12-31 | $470.87M | +3.3% |
| BillionToOne, Inc. (BLLN) | 2025-12-31 | $480.11M | n/m |
| Personalis, Inc. (PSNL) | 2025-12-31 | $261.19M | +28.7% |
| Caris Life Sciences, Inc. (CAI) | 2025-12-31 | $577.31M | n/m |
| Fulgent Genetics, Inc. (FLGT) | 2025-12-31 | $1.11B | -1.9% |
| Veracyte, Inc. (VCYT) | 2025-12-31 | $1.31B | +11.4% |
| Guardant Health, Inc. (GH) | 2025-12-31 | -$99.31M | n/m |
Compare CELC, CDNA, CSTL, BLLN side by side · Screen every company in Services-Medical Laboratories ↗